These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12051932)

  • 1. Contrasting IgG structures reveal extreme asymmetry and flexibility.
    Saphire EO; Stanfield RL; Crispin MD; Parren PW; Rudd PM; Dwek RA; Burton DR; Wilson IA
    J Mol Biol; 2002 May; 319(1):9-18. PubMed ID: 12051932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma.
    Harris LJ; Larson SB; Hasel KW; Day J; Greenwood A; McPherson A
    Nature; 1992 Nov; 360(6402):369-72. PubMed ID: 1448155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide connectivity of human immunoglobulin G2 structural isoforms.
    Martinez T; Guo A; Allen MJ; Han M; Pace D; Jones J; Gillespie R; Ketchem RR; Zhang Y; Balland A
    Biochemistry; 2008 Jul; 47(28):7496-508. PubMed ID: 18549248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic structure of an intact IgG1 monoclonal antibody.
    Harris LJ; Skaletsky E; McPherson A
    J Mol Biol; 1998 Feb; 275(5):861-72. PubMed ID: 9480774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility of human IgG subclasses.
    Roux KH; Strelets L; Michaelsen TE
    J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of human Fc gamma in closed-hinge or open-hinge configuration to Fab'gamma and analogous ligands.
    Stevenson GT; Anderson VA; Kan KS; Worth AT
    J Immunol; 1997 Mar; 158(5):2242-50. PubMed ID: 9036971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric.
    Ashish ; Solanki AK; Boone CD; Krueger JK
    Biochem Biophys Res Commun; 2010 Jan; 391(1):947-51. PubMed ID: 19995532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
    Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
    Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V; Damschroder MM; Leach W; Wu H; Dall'Acqua WF
    Mol Immunol; 2008 Apr; 45(7):1872-82. PubMed ID: 18078997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
    Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
    J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.